Abiopharma

News list

Director Collins Michelle T 🟡 adjusted position in 0 shares (1 derivative) of DELUXE CORP (DLX) Transaction Date: Aug 20, 2026 | Filing ID: 000012

Full text

News bot Aug. 20, 2026, 4:34 p.m.
🔍 Collins Michelle T (Director)

Company: DELUXE CORP (DLX)

Report Date: 2026-08-20
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 6,279
- Total shares sold: 6,279
Detailed Transactions and Holdings:
- Acquired 6,279 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,279.00 | transaction_form_type: 4
- Sold 6,279 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2026-08-20 | Exercise: 2026-08-20 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Transaction reflects vesting and conversion into shares on a one-for-one basis of restricted stock units previously awarded.